Pricing Log in Create free account
Saturday 17 October 2026 Export EHC’s income statement to Excel — free account

Encompass Health Corporation

EHC Healthcare Medical Care Facilities

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.58%, EPS grew 9.93%, free cash flow fell 45.0% and total debt rose 7.09%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.

127.87 0.10 +0.08%
Market cap
$12.6B
P/E
20.6×
Fwd P/E
16.8×
Dividend yield
0.61%
F-score
7/9
Altman Z
3.25
Beneish M
−2.71
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 47.79
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — 2 1 — 2 — — 5 — —
Insider Ownership 1.16%

Capital & Financial Ratios $m

Market Cap 12,600.00
Revenue 6,206.10
Net Income 833.30
Free Cash Flow 413.40
Net Debt 2,500.50
Current Ratio 1.19
Debt/Equity 0.77
P/E ratio 20.56
Fwd P/E 16.80
P/S ratio 2.04
P/B ratio 3.71
Past 5Y EPS Growth 14.22%
This Y EPS Growth 12.14%
Next Y EPS Growth 9.27%
Next Y revenue growth 8.84%
Next 5Y EPS Growth 10.18%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.4×, against a ten-year median of 2.0×; over the ten years it ranged from 1.5× in 2017 to 2.7× in 2021.
P/E against its own 10 years 69.70%
10-year low 10-year high
P/S against its own 10 years 95.80%
10-year low 10-year high
P/B against its own 10 years 91.37%
10-year low 10-year high
EV/Sales against its own 10 years 90.38%
10-year low 10-year high
EV/FCF against its own 10 years 63.32%
10-year low 10-year high

Dividends

Payout Ratio 0.13
Annual Dividend Rate 0.78
Annual Dividend Yield 0.61%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.78
0.19
0.19
0.19
0.21
2025 0.70
0.17
0.17
0.17
0.19
2024 0.47
0.15
0.15
0.17
2023 0.60
0.15
0.15
0.15
0.15
2022 0.80
0.22
0.28
0.15
0.15
2021 0.89
0.22
0.22
0.22
0.22
2020 0.89
0.22
0.22
0.22
0.22
2019 0.88
0.21
0.21
0.22
0.22
2018 0.83
0.20
0.20
0.21
0.21
2017 0.78
0.19
0.19
0.20
0.20
2016 0.75
0.18
0.18
0.19
0.19
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 104 123 103 134
Receivables 612 599 619 687
Inventory — — — —
Other 92 123 130 220
842 887 906 1,041
2023 2024 2025 Q'26
Payables 170 171 178 222
ST’ Debt 25 139 44 36
Other 212 246 290 —
656 841 836 873

Compound Annual Growth %

10y 5y 3y
Sales 6.66% 10.72% 10.92%
Cash Flow 8.88% 10.78% 18.54%
Earnings 12.05% 14.78% 27.84%
Book Value 15.23% 10.31% 20.78%

Revenue $m

Mar Jun Sep Dec Year
’26 1,587 1,597 — — —
’25 1,455 1,458 1,478 1,545 5,935
’24 1,316 1,301 1,351 1,405 5,373
’23 1,160 1,187 1,207 1,247 4,801
’22 1,059 1,063 1,090 1,137 4,349
’21 1,230 1,288 1,011 486 4,015
’20 1,182 1,074 1,174 136 3,566
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 313 283 — — —
’25 289 270 271 346 1,176
’24 239 217 268 279 1,003
’23 228 207 215 201 851
’22 219 245 70 172 706
’21 159 256 178 124 716
’20 29 222 173 280 705
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 151 62 — — —
’25 126 113 84 117 439
’24 99 61 120 80 360
’23 128 85 66 (11) 268
’22 106 132 (79) (47) 112
’21 60 132 74 (102) 164
’20 (54) 135 83 137 300
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 1.93 1.54 — — —
’25 1.48 1.39 1.24 1.43 5.54
’24 1.10 1.12 1.06 1.18 4.46
’23 0.87 0.90 0.84 0.86 3.47
’22 0.87 0.49 0.45 0.89 2.70
’21 1.07 1.13 1.00 0.91 4.11
’20 0.87 0.34 0.78 0.86 2.85
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 24.07 30.42 39.12 45.14 38.19 44.80 42.19 51.15 65.99 87.85

Analyst estimates 2026–2028

Powerpack
High 34.51 40.10 65.60 58.03 69.30 71.34 59.91 72.06 104.55 127.99
People
People Employees 27,968 29,370 30,060 31,570 43,000 43,400 35,000 38,000 40,000 42,000
Revenue/emp, $m 0.13 0.13 0.14 0.15 0.08 0.09 0.12 0.13 0.13 0.14
Income, $m
Income, $m Revenue 3,643 3,914 4,277 4,605 3,566 4,015 4,349 4,801 5,373 5,935
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
EBT 482 496 493 562 353 505 451 607 750 953
EBT margin, % 13.23 12.68 11.53 12.21 9.90 12.58 10.37 12.65 13.95 16.06
Net income 318 350 375 446 369 517 366 463 597 759
Depreciation 186 193 204 223 210 227 253 283 309 338
Per share, $
Per share, $ Revenue 40.88 41.77 43.69 46.99 36.17 40.55 43.84 48.25 53.79 59.06
Earnings 2.77 2.73 2.98 3.65 2.87 4.15 2.72 3.51 4.53 5.62
Cash flow 7.19 7.03 7.79 6.48 7.15 7.23 7.11 8.55 10.04 11.70
Capex (2.01) (2.65) (2.82) (4.12) (4.10) (5.58) (5.99) (5.86) (6.43) (7.33)
Free cash flow 5.18 4.37 4.97 2.36 3.04 1.65 1.13 2.69 3.61 4.37
Book value 10.42 14.89 15.90 17.28 19.98 23.81 18.41 22.67 27.96 32.01
Shares, m 89 94 98 98 99 99 99 100 100 101
Valuation, ×
Valuation, × P/E 11.95 14.92 16.53 15.10 22.92 12.51 21.94 19.13 20.30 18.85
P/S 0.81 0.98 1.12 1.17 1.82 1.28 1.36 1.39 1.72 1.80
P/B 3.17 2.75 3.09 3.19 3.29 2.18 3.23 2.96 3.30 3.32
EV/Sales 1.61 1.61 1.68 1.80 2.66 2.07 1.98 1.94 2.16 2.20
EV/FCF 12.71 15.22 14.62 37.47 34.40 58.74 93.51 39.02 35.08 31.87
Cash, $m
Cash, $m Operating cash flow 640 658 762 635 705 716 706 851 1,003 1,176
Capex (179) (249) (276) (404) (405) (552) (594) (583) (642) (736)
Free cash flow 461 410 486 231 300 164 112 268 360 439
Balance, $m
Balance, $m Working capital 179 185 (10) 35 231 173 141 185 46 70
Total debt 3,016 2,578 2,514 3,063 3,289 3,278 2,767 2,713 2,498 2,491
Net debt 2,915 2,461 2,386 2,910 3,000 3,166 2,714 2,608 2,375 2,388
Shareholders’ equity 929 1,395 1,557 1,693 1,970 2,357 1,826 2,255 2,793 3,218
Returns, %
Returns, % ROA 5.33 5.68 5.82 6.37 4.54 6.19 4.34 6.00 7.21 8.31
ROIC 10.55 10.35 9.98 9.30 6.61 7.45 8.68 9.40 10.45 11.74
ROE 28.99 23.33 19.80 22.07 15.52 19.05 12.96 17.25 18.06 18.84
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Encompass Health Corporation vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
THC Tenet Healthcare Corporation $22.2B 10.3× 6.4× +14.61% (above 0%: growing) +212.97% (above 0%: growing) −43.88% (below 0%: shrinking) 46.78% 24.85% Compare
EHC Encompass Health Corporation $12.6B 20.6× 16.8× +9.58% (above 0%: growing) +9.93% (above 0%: growing) −45.01% (below 0%: shrinking) 100.00% 17.85%
DVA DaVita Inc. $12.1B 15.0× 13.1× +5.17% (above 0%: growing) +56.49% (above 0%: growing) +49.36% (above 0%: growing) 32.70% 16.29% Compare
FMS Fresenius Medical Care AG & Co. KGaA $11.8B 11.5× 12.5× +3.89% (above 0%: growing) +6.82% (above 0%: growing) +1.57% (above 0%: growing) 26.95% 9.58% Compare
UHS Universal Health Services, Inc. $11.0B 7.5× 6.1× +8.27% (above 0%: growing) +9.47% (above 0%: growing) −23.78% (below 0%: shrinking) 90.87% 11.14% Compare
ENSG The Ensign Group, Inc. $10.4B 26.9× 24.1× +17.33% (above 0%: growing) +16.22% (above 0%: growing) +12.24% (above 0%: growing) 16.65% 8.50% Compare
PACS PACS Group, Inc. $7.6B 27.6× 16.8× +9.07% (above 0%: growing) +45.45% (above 0%: growing) +220.51% (above 0%: growing) 17.07% 7.66% Compare
CHE Chemed Corporation $6.7B 25.7× 20.4× +8.80% (above 0%: growing) +42.78% (above 0%: growing) −43.51% (below 0%: shrinking) 32.90% 13.25% Compare
CON Concentra Group Holdings Parent, Inc. $5.0B 24.9× 17.0× +10.03% (above 0%: growing) +45.71% (above 0%: growing) +91.62% (above 0%: growing) 31.70% 18.99% Compare
Median of peers $10.7B 19.9× 15.0× +8.94% +44.12% +6.91% 32.20% 12.20%

All 55 Medical Care Facilities stocks →

Encompass Health Corporation (EHC) key facts

  • Strength: Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.
  • Strength: Net income was $759.1 million, or $5.62 per share (basic), a net margin of 9.54%.
  • Encompass Health Corporation (EHC) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, EHC traded at $127.87, a market capitalization of $12.6 billion.
  • At that price the stock trades at 20.6× trailing-twelve-month earnings and 2.0× sales; its P/E is higher than 70% of its own readings over the past ten years.
  • Encompass Health Corporation pays an annual dividend of $0.78 per share, a yield of 0.61%, with a payout ratio of 12.7%.
  • Return on equity was 18.8% and debt-to-equity 0.77.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.25 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Encompass Health Corporation (EHC) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/EHC · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com